573 exam2 Flashcards
1st non-hormone therapy for vasomotor symptoms (how flashes) associated with menopause.___
Paroxetine mesylate/brisdelle
- TEST Q: Give ____ for: menopause + osteoporosis
Duavee / CE + bazedoxifene
(1st line = SERM, vaginal insert); dyspareunia DHEA: ___
Ospemifene / intrarosa
___ class: good for white/elderly/HTN + osteoporosis
thiazides
Adverse effects of HRT: ___
bloating, mstodynia, vaginal bleeding, headaches + estrogen,
rx of thromboembolic events (strokes), increased risk of pancreatitis
HRT does NOT increase rx of CV disease when started in women under age__ and does not affect the rx of dying from CV disease.
60
ARB is THE drug for the type __diabetic
2
sideroblastic anemia
Iron
Ferritin
TIBI
Iron- increased
Ferritin- increased
TIBI- decreased
• Immature RBCs in bone marrow, cannot utilize iron, builds up in mitochondria and blood, binds to transferrin
_____ sideroblasts within bone marrow (biopsy)= diagnostic
Ringed
Vulvovaginal atrophy: mild ___, mod/severe ____
mild- lube
mod/severe (vag estrogen / HT)
Menopause:
______: menopause + osteoporosis (SERM + CE)
Duavee / CE + bazedoxifene
____spine/low impact hip fx/osteoporosis;
osteopenia + FRAX scores = hip >3%; major fx >20% can tx with
biphos.; full glass of H2O, upright 40 min after; 5 yr cont à half-life
bone is 10 year; follow-up BMD
Bisphosphonates (Fosomax):
Osteoporosis:
Side effects of SERMS Raloxifene/Evista:
HF, vag dry, dec breast cx, NOT for preg/dvts
Osteoporosis: tx
______ new bone matrix; need Ca+VitD, biphos 2 yr post tx
Teripartide/Forteo:
Osteoporosis: tx
_____ SubQ q6mo; if dc – start biphos r/t inc fx risk
Denosumab/Prolia/Xgeva: